News & Articles

Revvity’s Euroimmun shares insights on the role of amyloid-beta, tau, neurofilament and APOE genotype in Alzheimer’s disease diagnostics

Revvity launches its first set of IVD Mimix reference standards, providing diagnostic labs with trusted quality controls for optimizing tests and monitoring workflows

Revvity is set to unveil its new Phenologic.AI software at SLAS2025 International Conference & Exhibition in San Diego, California

Collaboration to advance newborn genetic screening, leveraging cutting-edge genomics research and laboratory expertise to detect rare conditions early

APOE genotyping allows assessment of a patient’s risk for adverse effects from new anti-amyloid therapy for Alzheimer’s

Collaborative project to develop next-generation cell platform for viral vector production receives £1.1 million grant from Innovate UK & NRC

The North Carolina-based study will continue to test enrolled newborns for hundreds of childhood-onset rare genetic conditions

Partnership aims to expand CE-IVD molecular assay offerings

The new platform promises to substantially lower hands-on time, allowing for increased lab productivity

Showcase will include more than 40 products from its life sciences and diagnostics protfolio